Incyte Corporation
INCY
$62.53
$0.500.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.05B | 1.18B | 1.14B | 1.04B | 880.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.05B | 1.18B | 1.14B | 1.04B | 880.89M |
| Cost of Revenue | 473.77M | 393.22M | 659.17M | 1.22B | 452.39M |
| Gross Profit | 579.13M | 785.48M | 478.70M | -171.26M | 428.50M |
| SG&A Expenses | 324.97M | 325.50M | 308.47M | 305.41M | 299.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 835.44M | 880.02M | 967.64M | 1.52B | 788.69M |
| Operating Income | 217.46M | 298.68M | 170.23M | -476.66M | 92.20M |
| Income Before Tax | 234.19M | 313.72M | 156.52M | -389.78M | 236.16M |
| Income Tax Expenses | 75.99M | 112.51M | 50.07M | 54.82M | 66.61M |
| Earnings from Continuing Operations | 158.20M | 201.21M | 106.46M | -444.60M | 169.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 158.20M | 201.21M | 106.46M | -444.60M | 169.55M |
| EBIT | 217.46M | 298.68M | 170.23M | -476.66M | 92.20M |
| EBITDA | 239.83M | 325.32M | 192.75M | -454.61M | 114.14M |
| EPS Basic | 0.82 | 1.04 | 0.55 | -2.04 | 0.76 |
| Normalized Basic EPS | 0.80 | 1.04 | 0.63 | -1.23 | 0.38 |
| EPS Diluted | 0.80 | 1.02 | 0.54 | -2.04 | 0.75 |
| Normalized Diluted EPS | 0.78 | 1.01 | 0.62 | -1.23 | 0.37 |
| Average Basic Shares Outstanding | 193.71M | 193.15M | 192.63M | 218.18M | 224.48M |
| Average Diluted Shares Outstanding | 198.20M | 197.42M | 195.84M | 218.18M | 227.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |